Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Intangibles (2016 - 2025)

Haemonetics (HAE) has 15 years of Intangibles data on record, last reported at $487.8 million in Q3 2024.

  • For Q3 2024, Intangibles rose 94.74% year-over-year to $487.8 million; the TTM value through Sep 2024 reached $487.8 million, up 94.74%, while the annual FY2023 figure was $275.8 million, 11.12% down from the prior year.
  • Intangibles reached $487.8 million in Q3 2024 per HAE's latest filing, down from $494.9 million in the prior quarter.
  • Across five years, Intangibles topped out at $494.9 million in Q2 2024 and bottomed at $119.7 million in Q4 2020.
  • Average Intangibles over 5 years is $286.2 million, with a median of $292.6 million recorded in 2022.
  • Peak YoY movement for Intangibles: surged 174.58% in 2021, then decreased 15.11% in 2022.
  • A 5-year view of Intangibles shows it stood at $119.7 million in 2020, then skyrocketed by 181.71% to $337.2 million in 2021, then dropped by 15.68% to $284.4 million in 2022, then decreased by 11.91% to $250.5 million in 2023, then skyrocketed by 94.74% to $487.8 million in 2024.
  • Per Business Quant database, its latest 3 readings for Intangibles were $487.8 million in Q3 2024, $494.9 million in Q2 2024, and $250.5 million in Q3 2023.